What's Happening?
A recent survey conducted by Lindus Health, a clinical trial company, has highlighted a significant gap between consumer expectations and the information provided by health product manufacturers and physicians. The survey, which involved 175 participants, revealed that transparency regarding side effects and long-term safety are the primary factors influencing American consumers' decisions when purchasing health products. Despite the importance of these factors, less than 14% of respondents adhere to their physician's recommendations. The survey also found that over half of the participants expressed a desire for easier access to information on side effects, product usage, and safety, indicating a pressing need for greater transparency in consumer health.
Why It's Important?
The findings underscore a critical 'trust gap' in the consumer health market, where a lack of clear scientific evidence leads to skepticism and reluctance to adopt new health products. This skepticism extends to digital health technologies, with only 29% of respondents using such tools, while traditional options like vitamins and supplements remain popular due to their established research data. Lindus Health aims to bridge this divide by conducting high-quality clinical trials and real-world evidence studies to provide robust data that can help consumers make informed decisions. Addressing this trust gap is crucial for the future of digital health and consumer confidence in health products.
What's Next?
Lindus Health plans to focus on generating high-quality evidence to support consumer health products, aiming to enhance transparency and trust. This initiative may lead to increased adoption of digital health technologies and new health products as consumers gain access to reliable data. The company's efforts could also influence manufacturers and healthcare providers to prioritize transparency and evidence-based information, potentially reshaping the consumer health market.
